Drugs of Abuse Array Ultra

Randox Toxicology offers the most comprehensive Drugs of Abuse (DoA) test menu across multiple matrices. Our level of expertise in toxicology research and development allows us to adapt quickly to ever-changing market influences and develop assays for current and novel drug trends. Following our customer’s feedback, we developed DoA ULTRA, the most extensive DoA biochip array.

DoA ULTRA detects up to 20 targeted drugs, offering the largest cross-reactivity profile of over 240 analytes. Excellent assay precision and performance eliminates false reporting, therefore reducing unnecessary confirmatory tests and time lost in the laboratory as a result. Our biochip arrays offer CVs typically less than 10%, producing an accurate drug profile to ensure confidence in results.

Product catalogue number varies depending on analyser and matrix used:

 UrineWhole Blood
Evidence InvestigatorEV4103EV4056
Contact Us

Cross Reactivities

AnalyteLODCompoundd-Amph Assay (%CR)
Amphetamine2.76 ng/mLTBC
Barbiturate3.67 ng/mLTBCTBC
Benzodiazepines I0.21 ng/mLTBCTBC
Benzodiazepines II0.6 ng/mLTBCTBC
Benzoylecgonine/Cocaine1.03 ng/mLTBCTBC
Buprenorphine0.11 ng/mLTBCTBC
Dextromethorphan0.0175 ng/mlTBCTBC
Fentanyl0.09 ng/mLTBCTBC
Generic Opioids0.31 ng/mlTBCTBC
Meprobamate1.81 ng/mlTBCTBC
Methadone1.46 ng/mLTBCTBC
Methamphetamine10 ng/mLTBCTBC
Opiate0.13 ng/mlTBCTBC
Oxycodone I0.25 ng/mlTBCTBC
Oxycodone II0.18 ng/mlTBCTBC
Phencyclidine0.27 ng/mLTBCTBC
Tricyclic Antidepressants2.77 ng/mLTBCTBC
Zolpidem0.35 ng/mLTBCTBC

*All data in the above table refers to our whole blood matrix.